GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED

Other languages Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Shanghai S.E.

Equities

600332

CNE000001733

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 09/05/2024 am IST			5-day change	1st Jan Change
32.22 ^CNY	+0.16%		+0.44%	+12.66%

26/04	Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
18/03	Baiyunshan Pharmaceutical's 2023 Profit Rises 2%	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Baiyunshan Pharmaceutical's 2023 Profit Rises 2%	18/03
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Final Ordinary Dividend for the Year Ended 31 December 2023	15/03
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Baiyunshan Pharma's Unit Gets Green Light to Produce Hepatitis B Drug	01/03
Guangzhou Pharma Unit Gets Green Light to Trial Oral Liquid Drug	09/02
Guangzhou Baiyunshan Pharmaceutical Arm Floats 1 Billion Yuan Biomedical VC Fund	19/12
Guangzhou Baiyunshan Pharmaceutical Ends Spin-Off Plans, Seeks China Listing for Subsidiary	19/12
Guangzhou Pharma Expands Scope of Drug Production License	13/11
Guangzhou Baiyunshan Pharmaceutical's Profit Up 11% in Q3	30/23/30
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30
Baiyunshan Pharmaceutical Reports Increase in H1 Attributable Profit	13/23/13
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	17/23/17
Guangzhou Pharma Registers Pain-Relief, Anti-Inflammatory Drugs in Russia	26/23/26
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 30, 2023	27/23/27
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Election of the Supervisor Representing the Employees of the 9th Session of the Supervisory Committee	25/23/25
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Announces Final Dividend for the Year Ended 31 December 2022	17/23/17
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	17/23/17
Baiyunshan Pharma to Inject 334 Million Yuan Into New Fund	02/23/02
Baiyunshan Pharma Gets Nod for Tablets for Male Patients	09/23/09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Shanghai S.E.

Equities

600332

CNE000001733

Other languages

Filters